ARCHIVES

Leptin Could Be Indicator Of Breast Cancer Risk

This article is from The Cancer Letter archive.

Vol. 26 No. 4 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

In Brief: William Roper To Head Health Research Center; Announcement Of New NIH director Is Imminent

July 2, 1993

Cediranib Demonstates Control In Alveolar Soft Part Sarcoma

May 31, 2013

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989